Doximity's (DOCS) Q3 numbers beat estimates; Jefferies 'surprised at weakness' in shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Doximity, Inc. (DOCS) Tops Q3 EPS by 5c, provides guidance
February 8, 2024 4:03 PM ESTDoximity, Inc. (NYSE: DOCS) reported Q3 EPS of $0.29, $0.05 better than the analyst estimate of $0.24. Revenue for the quarter came in at $135.3 million versus the consensus estimate of $127.5 million.
GUIDANCE:
Doximity, Inc. sees Q4 2024 revenue of $115.9-116.9 million, versus the consensus of $118.1... More
